$USAQ
QHSLab Inc Stock $usaq

$usaq Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223009477 Filed on March 29, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$352.8K	$267.7K	$1.243M
YoY Change	-0.71%	-18.87%	-12.11%
Cost Of Revenue	$165.5K	$132.7K	$623.7K
YoY Change	-0.71%	-15.49%	-16.14%
Gross Profit	$187.3K	$135.0K	$619.5K
YoY Change	-0.71%	-21.94%	-7.64%
Gross Profit Margin	53.1%	50.43%	49.83%
Selling, General & Admin	$226.5K	$208.6K	$917.8K
YoY Change	11.69%	-11.67%	-12.26%
% of Gross Profit	120.92%	154.47%	148.15%
Research & Development	$63.55K	$54.12K	$190.1K
YoY Change	119.28%	93.49%	109.22%
% of Gross Profit	33.92%	40.08%	30.69%
Depreciation & Amortization	$36.64K	$36.64K	$128.0K
YoY Change	103.24%	103.22%	254.85%
% of Gross Profit	19.56%	27.14%	20.65%
Operating Expenses	$308.1K	$280.7K	$1.180M
YoY Change	23.33%	-0.5%	0.6%
Operating Profit	-$120.8K	-$145.7K	-$560.5K
YoY Change	97.54%	33.49%	11.6%
Interest Expense	$71.80K	-$70.50K	$433.4K
YoY Change	-156.46%	-49.57%	-275.85%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$192.6K	-$216.2K	-$996.0K
YoY Change	1.19%	-20.04%	29.32%
Income Tax
% Of Pretax Income
Net Earnings	-$192.6K	-$216.2K	-$996.0K
YoY Change	1.18%	-20.04%	29.32%
Net Earnings / Revenue	-54.58%	-80.76%	-80.12%
Basic Earnings Per Share	-$0.02		-$0.11
Diluted Earnings Per Share	-$0.02	-$0.02	-$0.11
COMMON SHARES
Basic Shares Outstanding	9.316M shares	9.316M shares	8.997M shares
Diluted Shares Outstanding	9.316M shares		8.997M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$93.08K	$178.7K	$178.7K
YoY Change	-40.16%	-37.71%	-37.71%
Cash & Equivalents	$93.08K	$178.7K	$178.7K
Short-Term Investments
Other Short-Term Assets	$9.730K	$7.310K	$7.310K
YoY Change	-86.47%	-67.81%	-67.81%
Inventory	$27.30K	$51.84K	$51.84K
Prepaid Expenses
Receivables	$76.24K	$47.73K	$47.73K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$206.3K	$285.6K	$285.6K
YoY Change	-47.98%	-35.94%	-35.94%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.635M	$1.672M	$1.672M
YoY Change	-8.23%	-5.15%	-5.15%
TOTAL ASSETS
Total Short-Term Assets	$206.3K	$285.6K	$285.6K
Total Long-Term Assets	$1.635M	$1.672M	$1.672M
Total Assets	$1.842M	$1.957M	$1.957M
YoY Change	-15.47%	-11.37%	-11.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$187.4K	$85.74K	$85.74K
YoY Change	466.98%	320.93%	320.91%
Accrued Expenses	$18.99K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$288.4K	$342.4K	$1.162M
YoY Change	-53.03%	34.87%	114.34%
Long-Term Debt Due	$288.4K	$342.4K	$342.4K
YoY Change	-15.73%	34.87%	34.87%
Total Short-Term Liabilities	$1.811M	$1.707M	$1.707M
YoY Change	74.86%	95.08%	95.08%
LONG-TERM LIABILITIES
Long-Term Debt	$141.1K	$174.4K	$174.4K
YoY Change	-69.19%	-65.33%	-65.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$141.1K	$174.4K	$174.4K
YoY Change	-69.78%	-65.77%	-65.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.811M	$1.707M	$1.707M
Total Long-Term Liabilities	$141.1K	$174.4K	$174.4K
Total Liabilities	$1.952M	$1.881M	$1.881M
YoY Change	29.92%	35.88%	35.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.707M	-$3.515M
YoY Change		39.54%
Common Stock	$932.00	$932.00
YoY Change		6.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$110.3K	$76.25K	$76.25K
YoY Change
Total Liabilities & Shareholders Equity	$1.842M	$1.957M	$1.957M
YoY Change	-15.47%	-11.37%	-11.37%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$192.6K	-$216.2K	-$996.0K
YoY Change	1.18%	-20.04%	29.32%
Depreciation, Depletion And Amortization	$36.64K	$36.64K	$128.0K
YoY Change	103.24%	103.22%	254.85%
Cash From Operating Activities	$1.702K	-$69.78K	-$351.0K
YoY Change	-101.24%	-41.17%	-1.06%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$37.12K
YoY Change		-100.0%	-124.02%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities		$0.00	-$37.12K
YoY Change		-100.0%	-75.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$50.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$87.32K	10.55K	$280.0K
YoY Change	-301.89%	-111.54%	-60.11%
NET CHANGE
Cash From Operating Activities	$1.702K	-69.78K	-$351.0K
Cash From Investing Activities		0.000	-$37.12K
Cash From Financing Activities	-$87.32K	10.55K	$280.0K
Net Change In Cash	-$85.62K	-59.23K	-$108.2K
YoY Change	-34.79%	-76.9%	-156.18%
FREE CASH FLOW
Cash From Operating Activities	$1.702K	-$69.78K	-$351.0K
Capital Expenditures		$0.00	$37.12K
Free Cash Flow		-$69.78K	-$388.1K
YoY Change		-3.37%	93.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000856984
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	USAQ	Accrued Interest Expenses Non Current AccruedInterestExpensesNonCurrent		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	USAQ	Unearned Stock Compensation UnearnedStockCompensation		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	USAQ	Longterm Debt And Accrued Interest Converted To Shares Of Preferred Stock LongtermDebtAndAccruedInterestConvertedToSharesOfPreferredStock		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	USAQ	Common Stock Issued For Debt Issuance Costs CommonStockIssuedForDebtIssuanceCosts		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-19041
CY2022	dei	Entity Registrant Name EntityRegistrantName	QHSLab, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-1104301
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Northpoint Parkway
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 302
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	West Palm
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Beach
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33407
CY2022	dei	City Area Code CityAreaCode	(929)
CY2022	dei	Local Phone Number LocalPhoneNumber	379-6503
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 Par Value
CY2022	dei	Trading Symbol TradingSymbol	USAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1857543	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9315508	shares
CY2022	dei	Auditor Name AuditorName	Accell Audit and Compliance, P.A.
CY2022	dei	Auditor Firm AuditorFirmId	3289
CY2022	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	178694	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286855	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47734	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	51840	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	65740	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	7310	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	22713	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	285578	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	445782	usd
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	167543	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1504332	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1576444	usd
CY2022Q4	us-gaap	Assets Assets	1957453	usd
CY2021Q4	us-gaap	Assets Assets	2208497	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	85743	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20370	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	116774	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58615	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	342391	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	253865	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1161918	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1706826	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	874954	usd
CY2021Q4	USAQ	Accrued Interest Expenses Non Current AccruedInterestExpensesNonCurrent	6521	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	174382	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	402956	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	174382	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	509477	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1881208	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1384431	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9315508	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9315508	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8756093	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8756093	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	932	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	876	usd
CY2021Q4	USAQ	Unearned Stock Compensation UnearnedStockCompensation	-6968	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3589837	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3348681	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3514896	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2518895	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	76245	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1957453	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2208497	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1243186	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1414421	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	623667	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	743673	usd
CY2022	us-gaap	Gross Profit GrossProfit	619519	usd
CY2021	us-gaap	Gross Profit GrossProfit	670748	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	530317	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	592068	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	387512	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	454008	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190117	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90874	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72112	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36056	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1180058	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1173006	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-560539	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-502258	usd
CY2022	us-gaap	Interest Expense InterestExpense	433442	usd
CY2021	us-gaap	Interest Expense InterestExpense	246490	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-21428	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-996001	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-770176	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-996001	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-770176	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8997129	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7861077	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-608326	usd
CY2021	USAQ	Warrants Issued As Deferred Financing Costs WarrantsIssuedAsDeferredFinancingCosts	221779	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	74332	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	802367	usd
CY2021	USAQ	Warrants Issued With Conversion Of Notes Payable WarrantsIssuedWithConversionOfNotesPayable	21428	usd
CY2021	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	124479	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	35683	usd
CY2021	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	862500	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30000	usd
CY2021	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	30000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-770176	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022	USAQ	Warrants Issued As Deferred Financing Costs WarrantsIssuedAsDeferredFinancingCosts	81183	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	6968	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	77925	usd
CY2022	USAQ	Warrants Issued With Conversion Of Notes Payable WarrantsIssuedWithConversionOfNotesPayable	2020	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	30084	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-996001	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	76245	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-996001	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-770176	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8230	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	127959	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	36056	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	305996	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	153883	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	30084	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	35683	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6968	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	198811	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-21428	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14510	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9952	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13900	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-33961	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-15403	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	11115	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	65374	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-125052	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4692	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	30237	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	59255	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	51498	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-350994	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-354738	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	37119	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	154571	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37119	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-154571	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	400000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	850000	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	239800	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	86000	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	379848	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	179178	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	85000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	279952	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	701822	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-108161	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	192513	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	286855	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94342	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178694	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	286855	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	71785	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	43023	usd
CY2021	USAQ	Longterm Debt And Accrued Interest Converted To Shares Of Preferred Stock LongtermDebtAndAccruedInterestConvertedToSharesOfPreferredStock	426081	usd
CY2022	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	77925	usd
CY2021	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	376286	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	1612500	usd
CY2021	USAQ	Common Stock Issued For Debt Issuance Costs CommonStockIssuedForDebtIssuanceCosts	30000	usd
CY2022	USAQ	Warrants Issued In Conjunction With Convertible Note Payable WarrantsIssuedInConjunctionWithConvertibleNotePayable	81183	usd
CY2021	USAQ	Warrants Issued In Conjunction With Convertible Note Payable WarrantsIssuedInConjunctionWithConvertibleNotePayable	221779	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zpmn2Uqc02z2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_82B_zwHrQeNnD1Ra">The Company</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QHSLab, Inc. (f/k/a USA Equities Corp.) (the “Company” or the “Registrant”) was incorporated in Delaware on September 1, 1983<span style="background-color: white">. </span>In 2015, the Company changed its name to USA Equities Corp. and created a wholly-owned subsidiary for future operations (“USAQ Corporation, Inc.”). In 2019, the Company consummated a share exchange agreement with the stockholders of Medical Practice Income, Inc. a Florida corporation (“MPI”). As a result of the acquisition, MPI became a wholly-owned subsidiary of the Company and the Company became engaged in value-based healthcare, informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. On September 23, 2021, the Company changed its state of incorporation from Delaware to Nevada as a result of a merger with and into its newly formed wholly-owned subsidiary, USA Equities Corp., a Nevada corporation (“USA Equities Nevada”), the surviving entity pursuant to an Agreement and Plan of Merger. USA Equities Nevada is deemed to be the successor to USA Equities Corp., the Delaware corporation. <span style="background-color: white">On April 19, 2022, the Company changed its name to QHSLab, Inc.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a medical device technology and software-as-a-service (“SaaS”) company focused on enabling primary care physicians (“PCP’s”) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zRgM7y9Ctbae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z11ffpwJEzM1">Use of Estimates</span>:</i> The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	167543	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	55847	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2022	USAQ	Net Operating Losses Carryforwards Expire Date NetOperatingLossesCarryforwardsExpireDate	begin to expire in 2027
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190117	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	90874	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3514896	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	55964	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	70474	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8230	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47734	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	223390	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	186271	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	55847	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	167543	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	186271	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	108168	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36056	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1504332	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1576444	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	55847	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021Q2	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1612500	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72112	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36056	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2022Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	426451	usd
CY2021Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	644158	usd
CY2022Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	128500	usd
CY2022Q1	us-gaap	Payments For Loans PaymentsForLoans	16305	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	16793	usd
CY2022Q4	us-gaap	Proceeds From Loans ProceedsFromLoans	111300	usd
CY2022Q4	us-gaap	Payments For Loans PaymentsForLoans	13776	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	93146	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1246000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	881000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	84082	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	238896	usd
CY2022Q4	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	1161918	usd
CY2021Q4	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	642104	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1161918	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.25
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2676647	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2119793	shares
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	30084	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	35683	usd
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6968	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	198811	shares
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	209160	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	161737	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6968	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	198811	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1100000	shares
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.12
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0021	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.763	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	738128	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	528968	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3514896	usd
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	begin to expire in 2027

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
usaq-20221231_cal.xml	Edgar Link	unprocessable
0001493152-23-009477-index-headers.html	Edgar Link	pending
0001493152-23-009477-index.html	Edgar Link	pending
0001493152-23-009477.txt	Edgar Link	pending
0001493152-23-009477-xbrl.zip	Edgar Link	pending
auditreport_001.jpg	Edgar Link	pending
auditreport_002.jpg	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usaq-20221231.xsd	Edgar Link	pending
usaq-20221231_def.xml	Edgar Link	unprocessable
usaq-20221231_lab.xml	Edgar Link	unprocessable
usaq-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USAQ
QHSLab Inc Stock $usaq

2023 Q1 Form 10-K Financial Statement

#000149315223009477 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ QHSLab Inc Stock $usaq

2023 Q1 Form 10-K Financial Statement

#000149315223009477 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ
QHSLab Inc Stock $usaq